Clinical trialNCT05671757RecruitingPhase 1/PHASE2Interventional

Daratumumab in Primary Antiphospholipid Syndrome

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment22Autoimmune Disorders

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Doruk Erkan, M.D., M.P.H.
Hospital for Special Surgery, New York: Division of Rheumatology
Study Chair
clinicaltrials.gov ↗
Jason Knight, M.D., Ph.D.
University of Michigan Health System: Department of Internal Medicine, Division of Rheumatology
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Johns Hopkins University
Baltimore, Maryland, United States
Shruti Chaturvedi
Recruiting
University of Michigan
Ann Arbor, Michigan, United States
Jason Knight
Recruiting
Mayo Clinic Rochester
Rochester, Minnesota, United States
Completed
Northwell Health
Great Neck, New York, United States
Nina Kello
Recruiting
Hospital for Special Surgery
New York, New York, United States
Doruk Erkan
Recruiting
Nyu Langone
New York, New York, United States
Michael Belmont, MD
Recruiting
Weill Cornell
New York, New York, United States
Maria De Sancho
Recruiting
Duke University
Durham, North Carolina, United States
Thomas Ortel, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 26 May 2023
Primary completion: 24 Jun 2026
Completion: 31 Mar 2027
Last update posted: 2 Apr 2026
Registered enrollment: 22
Registry id: NCT05671757

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.